These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 760408)

  • 1. Decreased renal plasma flow during propranolol treatment in essential hypertension.
    Falch DK; Odegaard AE; Norman N
    Acta Med Scand; 1979; 205(1-2):91-5. PubMed ID: 760408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension.
    Falch DK; Odegaard AE; Norman N
    Scand J Clin Lab Invest; 1978 Apr; 38(2):143-6. PubMed ID: 653302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of treatment and withdrawal of spironolactone in essential hypertension.
    Falch DK; Johansson R; Odegaard AE; Norman N
    Scand J Clin Lab Invest; 1979 Apr; 39(2):159-65. PubMed ID: 523964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of propranolol in conscious spontaneously hypertensive rats: central hemodynamics, plasma volume, and renal function during beta-blockade with propranolol.
    Smits JF; Coleman TG; Smith TL; Kasbergen CM; van Essen H; Struyker-Boudier HA
    J Cardiovasc Pharmacol; 1982; 4(6):903-14. PubMed ID: 6185781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac response to a small i.v. dose of dihydralazine, a safe drug for diagnostic tests?
    Falch DK; Norman N
    Acta Med Scand; 1978; 203(5):433-5. PubMed ID: 665311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure.
    Jacobsen BA; Fjeldborg P
    Scand J Clin Lab Invest; 1986 May; 46(3):289-92. PubMed ID: 3715380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal response to propranolol treatment in hypertensive humans.
    de Leeuw PW; Birkenhäger WH
    Hypertension; 1982; 4(1):125-31. PubMed ID: 6120895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central and renal circulation, renin and aldosterone in plasma during prazosin treatment in essential hypertension.
    Falch DK; Paulsen AQ; Odegaard AE; Norman N
    Acta Med Scand; 1979; 206(6):489-94. PubMed ID: 394581
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and hormonal effects of propranolol on patients with essential hypertension during head-up tilting: a comparison between normal and low cardiac index groups.
    Kida O; Morotomi Y; Higa T; Tanaka K
    Heart Vessels; 1985 Aug; 1(3):158-61. PubMed ID: 3913663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)].
    Pessina AC; Corgnati A; Palù CD
    G Ital Cardiol; 1976; 6(2):290-9. PubMed ID: 1010180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal blood flow and noradrenaline secretion during treatment with propranolol.
    de Leeuw PW; Punt R; Birkenhäger WH
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():477s-478s. PubMed ID: 7449302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.
    O'Connor DT; Preston RA; Sasso EH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S38-42. PubMed ID: 94638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.
    Sullivan JM; Adams DF; Hollenberg NK
    Circ Res; 1976 Oct; 39(4):532-6. PubMed ID: 963837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.